SONN
Sonnet BioTherapeutics
SONN
SONN
Delisted
SONN was delisted on the 2nd of December, 2025.
14 hedge funds and large institutions have $1.63M invested in Sonnet BioTherapeutics in 2021 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
Holders
14
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$291K | |
| 2 | +$164K | |
| 3 | +$114K | |
| 4 |
Bank of New York Mellon
New York
|
+$50.6K |
| 5 |
Jane Street
New York
|
+$44.3K |